We leveraged multiple large genomic datasets to show that missense POLE mutations outside of the exo-domain are detected in a non-trivial proportion of cancers and are not HCC or cancer-agnostic prognostic markers. This evidence concerns the gene POLE and hepatocellular carcinoma.